Efficacy of vital pulp therapy for carious pulp injury in permanent teeth: a study protocol for an open-label randomized controlled noninferiority trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
21 Oct 2024
Historique:
received: 05 07 2024
accepted: 14 10 2024
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 21 10 2024
Statut: epublish

Résumé

Vital pulp therapy (VPT) has recently been reported as an effective approach for preventing and treating carious pulp injury in permanent teeth. Compared with root canal treatment (RCT), which involves complete removal of the pulp tissue, VPT effectively maintains pulp vitality and retains the physiological functions of the pulp. In the research pool, large-scale randomized controlled trials evaluating the treatment outcome of VPT using calcium silicate cements and RCT in cariously exposed permanent teeth are lacking. Here, we present a monocentric clinical protocol to compare the effects of VPT using iRoot BP Plus (Innovative Bioceramix, Vancouver, BC, Canada) as a pulp-capping material with RCT. The proposed trial is an open-label, single-centre, randomized, controlled, noninferiority trial. In total, 462 patients will be included in this trial according to the following criteria: adult patients (18-50 years old), pulp exposure during the treatment of deep caries in mature permanent teeth, a diagnosis of reversible or partially irreversible pulpitis without apical translucency on X-ray, without periodontitis or systemic disease. Patients with signed informed consent forms will be enrolled and randomly divided into two groups (VPT and RCT) with a balanced treatment allocation (1:1). Clinical evaluations will be conducted at baseline and at 3, 6, 12, and 24 months after treatment, with the potential for extension. The primary outcome measure will be the duration of success. The secondary outcomes will include the success rate at the 1-year follow-up and any adverse reactions. The Kaplan‒Meier method and log-rank test will be used to compare the duration of success of both treatments. For other outcomes, the χ The results of this trial will provide a clinical reference for selecting treatments for carious pulp injuries in permanent teeth. ClinicalTrials.gov ChiCTR2100051369. The study has been registered in the Chinese Clinical Trial Registry (ChiCTR) ( www.chictr.org.cn ). Registered on 21 September 2021.

Sections du résumé

BACKGROUND BACKGROUND
Vital pulp therapy (VPT) has recently been reported as an effective approach for preventing and treating carious pulp injury in permanent teeth. Compared with root canal treatment (RCT), which involves complete removal of the pulp tissue, VPT effectively maintains pulp vitality and retains the physiological functions of the pulp. In the research pool, large-scale randomized controlled trials evaluating the treatment outcome of VPT using calcium silicate cements and RCT in cariously exposed permanent teeth are lacking. Here, we present a monocentric clinical protocol to compare the effects of VPT using iRoot BP Plus (Innovative Bioceramix, Vancouver, BC, Canada) as a pulp-capping material with RCT.
METHODS METHODS
The proposed trial is an open-label, single-centre, randomized, controlled, noninferiority trial. In total, 462 patients will be included in this trial according to the following criteria: adult patients (18-50 years old), pulp exposure during the treatment of deep caries in mature permanent teeth, a diagnosis of reversible or partially irreversible pulpitis without apical translucency on X-ray, without periodontitis or systemic disease. Patients with signed informed consent forms will be enrolled and randomly divided into two groups (VPT and RCT) with a balanced treatment allocation (1:1). Clinical evaluations will be conducted at baseline and at 3, 6, 12, and 24 months after treatment, with the potential for extension. The primary outcome measure will be the duration of success. The secondary outcomes will include the success rate at the 1-year follow-up and any adverse reactions. The Kaplan‒Meier method and log-rank test will be used to compare the duration of success of both treatments. For other outcomes, the χ
DISCUSSION CONCLUSIONS
The results of this trial will provide a clinical reference for selecting treatments for carious pulp injuries in permanent teeth.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov ChiCTR2100051369. The study has been registered in the Chinese Clinical Trial Registry (ChiCTR) ( www.chictr.org.cn ). Registered on 21 September 2021.

Identifiants

pubmed: 39434172
doi: 10.1186/s13063-024-08559-y
pii: 10.1186/s13063-024-08559-y
doi:

Substances chimiques

Silicates 0

Types de publication

Journal Article Clinical Trial Protocol

Langues

eng

Sous-ensembles de citation

IM

Pagination

700

Informations de copyright

© 2024. The Author(s).

Références

Friedman S, Mor C. The success of endodontic therapy–healing and functionality. J Calif Dent Assoc. 2004;32(6):493–503.
pubmed: 15344440
Moazami F, Sahebi S, Sobhnamayan F, Alipour A. Success rate of nonsurgical endodontic treatment of nonvital teeth with variable periradicular lesions. Iran Endod J. 2011;6(3):119–24.
pubmed: 23130063 pmcid: 3487520
Asgary S, Shadman B, Ghalamkarpour Z, Shahravan A, Ghoddusi J, Bagherpour A, et al. Periapical status and quality of root canal fillings and coronal restorations in iranian population. Iran Endod J. 2010;5(2):74–82.
pubmed: 23130031 pmcid: 3487502
Ng YL, Mann V, Gulabivala K. Tooth survival following non-surgical root canal treatment: a systematic review of the literature. Int Endod J. 2010;43(3):171–89.
doi: 10.1111/j.1365-2591.2009.01671.x pubmed: 20158529
Silva AA, Belladonna FG, Rover G, Lopes RT, Moreira EJL, De-Deus G, et al. Does ultraconservative access affect the efficacy of root canal treatment and the fracture resistance of two-rooted maxillary premolars? Int Endod J. 2020;53(2):265–75.
doi: 10.1111/iej.13219 pubmed: 31519039
Taha NA, Abuzaid AM, Khader YS. A randomized controlled clinical trial of pulpotomy versus root canal therapy in mature teeth with irreversible pulpitis: outcome, quality of life, and patients’ satisfaction. J Endod. 2023;49(6):624-631.e2.
doi: 10.1016/j.joen.2023.04.001 pubmed: 37080387
Passarelli PC, Pagnoni S, Piccirillo GB, Desantis V, Benegiamo M, Liguori A, et al. Reasons for tooth extractions and related risk factors in adult patients: a cohort study. Int J Environ Res Public Health. 2020;17(7):2575.
doi: 10.3390/ijerph17072575 pubmed: 32283707 pmcid: 7178127
European Society of Endodontology (ESE) developed by:, Duncan HF, Galler KM, Tomson PL, Simon S, El-Karim I, et al. European Society of Endodontology position statement: Management of deep caries and the exposed pulp. Int Endod J. 2019;52(7):923–34
Duncan HF. Present status and future directions-Vital pulp treatment and pulp preservation strategies. Int Endod J. 2022;55 Suppl 3(Suppl 3):497–511.
doi: 10.1111/iej.13688 pubmed: 35080024
Iaculli F, Rodríguez-Lozano FJ, Briseño-Marroquín B, Wolf TG, Spagnuolo G, Rengo S. Vital pulp therapy of permanent teeth with reversible or irreversible pulpitis: an overview of the literature. J Clin Med. 2022;11(14):4016.
doi: 10.3390/jcm11144016 pubmed: 35887779 pmcid: 9321233
Lin GSS, Hisham ARB, Cher CY, Cheah KK, Ghani NRNA, Noorani TY. Success rates of coronal and partial pulpotomies in mature permanent molars: a systematic review and single-arm meta-analysis. Quintessence Int Berl Ger 1985. 2021;52(3):196–208.
Sharma R, Kumar V, Logani A, Chawla A, Mir RA, Sharma S, et al. Association between concentration of active MMP-9 in pulpal blood and pulpotomy outcome in permanent mature teeth with irreversible pulpitis - a preliminary study. Int Endod J. 2021;54(4):479–89.
doi: 10.1111/iej.13437 pubmed: 33128238
Cushley S, Duncan HF, Lappin MJ, Tomson PL, Lundy FT, Cooper P, et al. Pulpotomy for mature carious teeth with symptoms of irreversible pulpitis: a systematic review. J Dent. 2019;88:103158.
doi: 10.1016/j.jdent.2019.06.005 pubmed: 31229496
Alqaderi H, Lee CT, Borzangy S, Pagonis TC. Coronal pulpotomy for cariously exposed permanent posterior teeth with closed apices: a systematic review and meta-analysis. J Dent. 2016;44:1–7.
doi: 10.1016/j.jdent.2015.12.005 pubmed: 26687672
American Association of Endodontists. AAE position statement on vital pulp therapy. J Endod. 2021;47(9):1340–4.
doi: 10.1016/j.joen.2021.07.015
Schwendicke F, Stolpe M. Direct pulp capping after a carious exposure versus root canal treatment: a cost-effectiveness analysis. J Endod. 2014;40(11):1764–70.
doi: 10.1016/j.joen.2014.07.028 pubmed: 25218524
Naved N, Umer F, Khowaja AR. Irreversible pulpitis in mature permanent teeth: a cost-effectiveness analysis of pulpotomy versus root canal treatment. BMC Oral Health. 2024;24(1):285.
doi: 10.1186/s12903-024-04052-9 pubmed: 38418999 pmcid: 10902936
Rao Q, Kuang J, Mao C, Dai J, Hu L, Lei Z, et al. Comparison of iRoot BP plus and calcium hydroxide as pulpotomy materials in permanent incisors with complicated crown fractures: a retrospective study. J Endod. 2020;46(3):352–7.
doi: 10.1016/j.joen.2019.12.010 pubmed: 32035640
Awawdeh L, Al-Qudah A, Hamouri H, Chakra RJ. Outcomes of vital pulp therapy using mineral trioxide aggregate or biodentine: a prospective randomized clinical trial. J Endod. 2018;44(11):1603–9.
doi: 10.1016/j.joen.2018.08.004 pubmed: 30292451
Zhu L, Yang J, Zhang J, Lei D, Xiao L, Cheng X, et al. In vitro and in vivo evaluation of a nanoparticulate bioceramic paste for dental pulp repair. Acta Biomater. 2014;10(12):5156–68.
doi: 10.1016/j.actbio.2014.08.014 pubmed: 25182220
De-Deus G, Canabarro A, Alves GG, Marins JR, Linhares ABR, Granjeiro JM. Cytocompatibility of the ready-to-use bioceramic putty repair cement iRoot BP Plus with primary human osteoblasts. Int Endod J. 2012;45(6):508–13.
doi: 10.1111/j.1365-2591.2011.02003.x pubmed: 22364572
Rifaey HS, Villa M, Zhu Q, Wang YH, Safavi K, Chen IP. Comparison of the osteogenic potential of mineral trioxide aggregate and endosequence root repair material in a 3-dimensional culture system. J Endod. 2016;42(5):760–5.
doi: 10.1016/j.joen.2016.02.001 pubmed: 26994596
Liu S, Wang S, Dong Y. Evaluation of a bioceramic as a pulp capping agent in vitro and in vivo. J Endod. 2015;41(5):652–7.
doi: 10.1016/j.joen.2014.12.009 pubmed: 25637192
Tian J, Zhang Y, Lai Z, Li M, Huang Y, Jiang H, et al. Ion release, microstructural, and biological properties of iRoot BP Plus and ProRoot MTA exposed to an acidic environment. J Endod. 2017;43(1):163–8.
doi: 10.1016/j.joen.2016.10.011 pubmed: 27939732
Giraud T, Jeanneau C, Bergmann M, Laurent P, About I. Tricalcium silicate capping materials modulate pulp healing and inflammatory activity in vitro. J Endod. 2018;44(11):1686–91.
doi: 10.1016/j.joen.2018.06.009 pubmed: 30217466
Han S, Zhang Q. Vital pulp therapy following pulpotomy in immature permanent teeth with carious exposure. J Clin Pediatr Dent. 2023;47(5):65–72.
pubmed: 37732438
Sheng M, Zhang D, Yan J, Li W. Relationship between time to hemostasis and outcomes of pulpotomy using iRoot BP Plus in symptomatic young permanent teeth: a prospective study. J Clin Pediatr Dent. 2023;47(6):142–9.
pubmed: 37997245
Liu SY, Gong WY, Liu MQ, Long YZ, Dong YM. Clinical efficacy observation of direct pulp capping using iRoot BP Plus therapy in mature permanent teeth with carious pulp exposure. Zhonghua Kou Qiang Yi Xue Za Zhi Zhonghua Kouqiang Yixue Zazhi Chin J Stomatol. 2020;55(12):945–51.
Guan X, Zhou Y, Yang Q, Zhu T, Chen X, Deng S, et al. Vital pulp therapy in permanent teeth with irreversible pulpitis caused by caries: a prospective cohort study. J Pers Med. 2021;11(11):1125.
doi: 10.3390/jpm11111125 pubmed: 34834477 pmcid: 8620894
Patro S, Meto A, Mohanty A, Chopra V, Miglani S, Das A, et al. Diagnostic accuracy of pulp vitality tests and pulp sensibility tests for assessing pulpal health in permanent teeth: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(15):9599.
doi: 10.3390/ijerph19159599 pubmed: 35954958 pmcid: 9367848
Ramani A, Sangwan P, Tewari S, Duhan J, Mittal S, Kumar V. Comparative evaluation of complete and partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: a randomized clinical trial. Int Endod J. 2022;55(5):430–40.
doi: 10.1111/iej.13714 pubmed: 35226769
Jassal A, Nawal RR, Yadav S, Talwar S, Yadav S, Duncan HF. Outcome of partial and full pulpotomy in cariously exposed mature molars with symptoms indicative of irreversible pulpitis: a randomized controlled trial. Int Endod J. 2023;56(3):331–44.
doi: 10.1111/iej.13872 pubmed: 36403208
Ricucci D, Loghin S, Siqueira JF. Correlation between clinical and histologic pulp diagnoses. J Endod. 2014;40(12):1932–9.
doi: 10.1016/j.joen.2014.08.010 pubmed: 25312886
Wolters WJ, Duncan HF, Tomson PL, Karim IE, McKenna G, Dorri M, et al. Minimally invasive endodontics: a new diagnostic system for assessing pulpitis and subsequent treatment needs. Int Endod J. 2017;50(9):825–9.
doi: 10.1111/iej.12793 pubmed: 28776717
Asgary S, Eghbal MJ, Shahravan A, Saberi E, Baghban AA, Parhizkar A. Outcomes of root canal therapy or full pulpotomy using two endodontic biomaterials in mature permanent teeth: a randomized controlled trial. Clin Oral Investig. 2022;26(3):3287–97.
doi: 10.1007/s00784-021-04310-y pubmed: 34854987
Koli B, Chawla A, Logani A, Kumar V, Sharma S. Combination of nonsurgical endodontic and vital pulp therapy for management of mature permanent mandibular molar teeth with symptomatic irreversible pulpitis and apical periodontitis. J Endod. 2021;47(3):374–81.
doi: 10.1016/j.joen.2020.10.010 pubmed: 33091455
Galani M, Tewari S, Sangwan P, Mittal S, Kumar V, Duhan J. Comparative evaluation of postoperative pain and success rate after pulpotomy and root canal treatment in cariously exposed mature permanent molars: a randomized controlled trial. J Endod. 2017;43(12):1953–62.
doi: 10.1016/j.joen.2017.08.007 pubmed: 29061359
Asgary S, Eghbal MJ, Fazlyab M, Baghban AA, Ghoddusi J. Five-year results of vital pulp therapy in permanent molars with irreversible pulpitis: a non-inferiority multicenter randomized clinical trial. Clin Oral Investig. 2015;19(2):335–41.
doi: 10.1007/s00784-014-1244-z pubmed: 24771228

Auteurs

Qian Zeng (Q)

Hospital of Stomatology, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510055, China.
Guangdong Provincial Clinical Research Center of Oral Diseases, Guangzhou, China.
Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510055, China.

Mingchang Chen (M)

Hospital of Stomatology, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510055, China.
Guangdong Provincial Clinical Research Center of Oral Diseases, Guangzhou, China.
Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510055, China.

Siyi Zheng (S)

Hospital of Stomatology, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510055, China.
Guangdong Provincial Clinical Research Center of Oral Diseases, Guangzhou, China.
Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510055, China.

Xi Wei (X)

Hospital of Stomatology, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510055, China. weixi@mail.sysu.edu.cn.
Guangdong Provincial Clinical Research Center of Oral Diseases, Guangzhou, China. weixi@mail.sysu.edu.cn.
Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510055, China. weixi@mail.sysu.edu.cn.

Hongyan Liu (H)

Hospital of Stomatology, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510055, China. liuhyan@mail.sysu.edu.cn.
Guangdong Provincial Clinical Research Center of Oral Diseases, Guangzhou, China. liuhyan@mail.sysu.edu.cn.
Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510055, China. liuhyan@mail.sysu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH